KORU Medical shares rise 15.47% intraday after reporting Q3 revenue exceeding estimates by $730,000 and raising 2025 guidance to $40.5M–$41M.

KORU Medical surged 15.47% intraday, with the company reporting Q3 revenue of $10.4 million, a 27% increase from the previous year, and raising its FY2025 revenue guidance to $40.5-$41 million.